XML 27 R15.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Accrued Expenses and Other Current Liabilities
 6 Months Ended
Jun. 30, 2024
Payables and Accruals [Abstract]  
Accrued Expenses and Other Current Liabilities Accrued Expenses and Other Current Liabilities
The components of accrued expenses and other current liabilities were as follows:
(in millions)June 30, 2024December 31, 2023
Accrued rebates$132.6 $144.0 
Employee compensation and related costs91.2 122.0 
Professional and consulting services50.3 34.1 
Other90.9 73.6 
Accrued expenses and other current liabilities$365.0 $373.7 
Product Warranty Costs
The Company provides a four-year warranty on Personal Diabetes Managers (“PDMs”) and Controllers sold in the United States and Europe and a five-year warranty on PDMs sold in Canada and may replace Pods that do not function in accordance with product specifications. The Company estimates its warranty obligation at the time the product is shipped based on historical experience and the estimated cost to service the claims. Cost to service the claims reflects the current product cost, reclaim costs, shipping and handling costs and direct and incremental distribution and customer service support costs. Since the Company continues to introduce new products and versions, the anticipated performance of the product over the warranty period is also considered in estimating warranty reserves. Warranty expense is recorded in cost of revenue in the consolidated statements of income. Reconciliations of the changes in the Company’s product warranty liability were as follows: 
Three Months Ended June 30,Six Months Ended June 30,
(in millions)2024202320242023
Product warranty liability at beginning of period$11.3 $39.2 $10.3 $62.1 
Warranty expense5.7 3.3 11.2 8.8 
Change in estimate(0.4)(0.8)(0.4)(8.8)
Warranty fulfillment(5.0)(20.4)(9.5)(40.8)
Product warranty liability at the end of period$11.6 $21.3 $11.6 $21.3 
During the fourth quarter of 2022, the Company issued two voluntary medical device correction notices (“MDCs”), one for its Omnipod DASH PDM relating to its battery and the other for its Omnipod 5 Controller relating to its charging port and cable. During the six months ended June 30, 2023, the Company revised the estimated liability for these MDCs by $8.8 million. This change in estimate primarily resulted from lower shipping costs for replacement DASH PDMs and lower expected distribution costs for Omnipod 5 Controllers. The liability related to the MDCs included in product warranty liability at December 31, 2023 was insignificant and no amount was remaining as of June 30, 2024.